The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 14, 2023

Filed:

Jun. 04, 2018
Applicant:

Fortus Medical, Inc., Minneapolis, MN (US);

Inventors:

Robert Assell, Minneapolis, MN (US);

Andy Freeman, Minneapolis, MN (US);

Assignee:

ForCyte Medical, LLC, Marietta, GA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 17/16 (2006.01); A61M 1/00 (2006.01); A61B 17/34 (2006.01); A61K 9/00 (2006.01); A61K 35/28 (2015.01); A61M 1/02 (2006.01); C12M 1/00 (2006.01); A61B 10/02 (2006.01); A61B 17/32 (2006.01); A61L 27/38 (2006.01);
U.S. Cl.
CPC ...
A61M 1/892 (2021.05); A61B 17/1635 (2013.01); A61B 17/3472 (2013.01); A61K 9/0019 (2013.01); A61K 35/28 (2013.01); A61M 1/0281 (2013.01); C12M 45/00 (2013.01); A61B 10/025 (2013.01); A61B 2010/0258 (2013.01); A61B 2017/320064 (2013.01); A61B 2217/005 (2013.01); A61L 27/3856 (2013.01); A61M 1/79 (2021.05); A61M 2202/0429 (2013.01); A61M 2202/09 (2013.01); A61M 2205/3389 (2013.01); A61M 2205/583 (2013.01); A61M 2205/7545 (2013.01); A61M 2210/02 (2013.01);
Abstract

A method of treating soft tissue conditions. A harvesting device is provided. The harvesting device is operably connected to a tissue processing device using tubing. An aperture is formed in a bone. The bone has an interior. The harvesting device is inserted through the aperture in the bone and into the interior of the bone. The harvesting device is manipulated to dissociate connective tissue progenitor cells in the interior of the bone. Tissue is aspirated from the interior of the bone. The connective tissue progenitor cells are separated from the aspirated tissue. The separated connective tissue progenitor cells are injected in a region of a body that is experiencing a soft tissue condition to treat the soft tissue condition.


Find Patent Forward Citations

Loading…